Development of a Static Balance Assessment Tool for High-Functioning Older Adults (KSVGH25-CT3-09) (KSVGH25-CT3-09)

December 17, 2025 updated by: Jia-Ling Hong

Development of a Static Balance Assessment Tool for High-Functioning Older Adults

This single-center interventional study aims to develop and validate a static balance assessment tool tailored for high-functioning older adults. Participants aged 65 years or older, who achieve a perfect score on the Short Physical Performance Battery and can maintain an open-eyes single-leg stance for at least 10 seconds, will be recruited. The assessment includes body composition measurement, open-eyes/closed-eyes single-leg stance, and the Balance Error Scoring System under firm and foam surface conditions. Each participant will undergo two testing sessions, 5-7 days apart, with both on-site and video-based scoring to determine test-retest reliability. The expected outcome is the development of an accurate and highly applicable static balance measurement tool to support healthy aging and fall prevention in community and long-term care settings.

Study Overview

Detailed Description

The study is conducted at Kaohsiung Municipal United Hospital, Taiwan, with the objective of creating a static balance assessment tool specifically designed for older adults who are physically high-functioning. Traditional balance tests, such as the open-eyes single-leg stance with a 30-second limit, often produce ceiling effects in this population, making it difficult to detect subtle differences in balance ability or evaluate the benefits of exercise programs. To address this limitation, the current study extends the open-eyes single-leg stance to a maximum of 60 seconds and incorporates a closed-eyes condition to increase task difficulty.

In addition, the Balance Error Scoring System, originally developed for concussion assessment, will be adapted for older adults. Balance Error Scoring System testing will be conducted under six conditions: double-leg stance, tandem stance, and single-leg stance, each performed on both firm and foam surfaces with eyes closed. This design simulates balance challenges encountered in daily life while minimizing fall risk.

Eligible participants (n=50) will be community-dwelling older adults aged ≥65 years, with perfect Short Physical Performance Battery scores and no recent lower limb injuries or neurological conditions. Each participant will complete two identical assessment sessions, spaced 5-7 days apart. Both on-site evaluators and independent assessors reviewing video recordings will score performance. The primary outcome is the test-retest reliability of each balance measure, quantified through statistical analysis.

The anticipated benefit of this study is to establish a reliable, sensitive, and practical balance assessment protocol that can be implemented in community health programs, long-term care facilities, and research settings. This tool aims to improve early detection of balance decline, guide intervention planning, and ultimately contribute to fall prevention and healthy aging initiatives in aging societies.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Jia-Ling Hong Physiotherapist
  • Phone Number: +886-7-5552565 ext 51705
  • Email: daben610357@gmail.com

Study Locations

    • Kaohsiung City
      • Kaohsiung City, Kaohsiung City, Taiwan, 813
        • Recruiting
        • Kaohsiung Municipal United Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 60 to 85 years
  • Able to walk independently without assistive devices
  • No self-reported balance disorders or history of recurrent falls in the past 6 months
  • Cognitively intact (Mini-Mental State Examination score ≥ 24)
  • Willing and able to provide informed consent

Exclusion Criteria:

  • Diagnosed neurological disorders affecting balance (e.g., Parkinson's disease, stroke with residual deficits)
  • Diagnosed neurological disorders affecting balance (e.g., Parkinson's disease, stroke with residual deficits)
  • Severe visual or vestibular impairment uncorrected by aids
  • Lower limb musculoskeletal disorders that limit mobility
  • Current participation in other interventional clinical trials
  • Unstable cardiovascular conditions (e.g., uncontrolled hypertension, recent myocardial infarction)
  • Severe visual or vestibular impairment uncorrected by aids
  • Lower limb musculoskeletal disorders that limit mobility
  • Current participation in other interventional clinical trials
  • Unstable cardiovascular conditions (e.g., uncontrolled hypertension, recent myocardial infarction)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Static Balance Assessment Group
Participants will undergo body composition measurement, open-eyes and closed-eyes single-leg stance test, and Balance Error Scoring System testing under firm and foam surface conditions. Each participant will complete two identical sessions, 5-7 days apart, with both on-site scoring and video-based scoring to determine test-retest reliability.
Participants will undergo a standardized static balance assessment protocol, including open-eyes and closed-eyes single-leg stance tests, as well as Balance Error Scoring System (BESS) testing under firm and foam surface conditions. Each participant will complete two identical sessions, 5-7 days apart, with both on-site scoring and video-based scoring performed by trained assessors to determine test-retest reliability.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Test-Retest Reliability of Static Balance Assessment Scores
Time Frame: Within 7 days after the first assessment

Description: Reliability will be evaluated using intra-class correlation coefficient (ICC) and Spearman correlation coefficient (ρ) between session 1 and session 2 scores for the following static balance tests:

Single-leg stance with eyes open Single-leg stance with eyes closed Balance Error Scoring System (BESS) under various surface conditions Scale Name: Balance Error Scoring System (BESS) Score Range: 0 (best balance) to 60 (worst balance) Interpretation: Higher BESS scores indicate worse balance performance.

Within 7 days after the first assessment
Short Physical Performance Battery (SPPB) - 4-Meter Walk Test
Time Frame: Within 7 days after the first assessment
Unit of Measure: Seconds (s) Description: Measures usual gait speed over a 4-meter distance. Interpretation: Lower time indicates better performance.
Within 7 days after the first assessment
Short Physical Performance Battery (SPPB) - 5-Times Sit-to-Stand Test
Time Frame: Within 7 days after the first assessment
Unit of Measure: Seconds (s) Description: Measures lower-limb strength and functional mobility. Interpretation: Lower time indicates better performance.
Within 7 days after the first assessment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Height
Time Frame: At baseline (first assessment)
Unit of Measure: Centimeters (cm)
At baseline (first assessment)
Body Weight
Time Frame: At baseline (first assessment)
Unit of Measure: Kilograms (kg)
At baseline (first assessment)
Body Mass Index (BMI)
Time Frame: At baseline (first assessment)
Unit of Measure: Kilograms per square meter (kg/m²) Calculated as weight in kilograms divided by height in meters squared.
At baseline (first assessment)
Whole-Body Skeletal Muscle Mass
Time Frame: At baseline (first assessment)

Unit of Measure: Kilograms (kg)

Description:

Whole-body skeletal muscle mass will be measured using bioelectrical impedance analysis (BIA) with the TANITA BC-545N body composition analyzer. Participants will stand barefoot and hold hand electrodes during the assessment.

At baseline (first assessment)
Single-Leg Stance Test - Eyes Open
Time Frame: Within 7 days after the first assessment

Test Name: Single-Leg Stance Test (Eyes Open) Unit of Measure: Seconds (s) Description: Participant stands unassisted on one leg with eyes open. The time is recorded until balance is lost or foot touches the ground.

Interpretation: Longer time indicates better static balance performance.

Within 7 days after the first assessment
Single-Leg Stance Test - Eyes Closed
Time Frame: Within 7 days after the first assessment

Test Name: Single-Leg Stance Test (Eyes Closed) Unit of Measure: Seconds (s) Description: Participant stands unassisted on one leg with eyes closed. The time is recorded until balance is lost or foot touches the ground.

Interpretation: Longer time indicates better static balance performance.

Within 7 days after the first assessment
Whole-Body Muscle Mass
Time Frame: At baseline (first assessment)

Unit of Measure: Kilograms (kg)

Description:

Whole-body muscle mass will be assessed using bioelectrical impedance analysis (BIA) with the TANITA BC-545N body composition analyzer.

At baseline (first assessment)
Segmental Muscle Mass - Upper and Lower Limbs and Trunk
Time Frame: At baseline (first assessment)

Unit of Measure: Kilograms (kg)

Description:

Segmental muscle mass of the right upper limb, left upper limb, trunk, right lower limb, and left lower limb will be measured using bioelectrical impedance analysis (BIA) with the TANITA BC-545N body composition analyzer.

At baseline (first assessment)
Whole-Body Body Fat Percentage
Time Frame: At baseline (first assessment)

Unit of Measure: Percentage (%)

Description:

Whole-body body fat percentage will be measured using bioelectrical impedance analysis (BIA) with the TANITA BC-545N body composition analyzer.

At baseline (first assessment)
Segmental Body Fat Percentage
Time Frame: At baseline (first assessment)

Unit of Measure: Percentage (%)

Description:

Segmental body fat percentage of the right upper limb, left upper limb, trunk, right lower limb, and left lower limb will be measured using bioelectrical impedance analysis (BIA) with the TANITA BC-545N body composition analyzer.

At baseline (first assessment)
Visceral Fat Level
Time Frame: At baseline (first assessment)

Unit of Measure: Arbitrary units (BIA-derived level)

Description:

Visceral fat level will be estimated using bioelectrical impedance analysis (BIA) with the TANITA BC-545N body composition analyzer.

At baseline (first assessment)
Basal Metabolic Rate
Time Frame: At baseline (first assessment)

Unit of Measure: Kilocalories per day (kcal/day)

Description:

Basal metabolic rate will be estimated using bioelectrical impedance analysis (BIA) with the TANITA BC-545N body composition analyzer.

At baseline (first assessment)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fall Frequency
Time Frame: At baseline (first assessment)
Unit: Number of falls in past 12 months
At baseline (first assessment)
Living Status
Time Frame: At baseline (first assessment)
Unit: Categorical (living alone / with others)
At baseline (first assessment)
Education Level
Time Frame: At baseline (first assessment)
Unit: Categorical (elementary, high school, etc.)
At baseline (first assessment)
Exercise Habit
Time Frame: At baseline (first assessment)
Unit: Categorical (Yes / No)
At baseline (first assessment)
Exercise Duration
Time Frame: At baseline (first assessment)
Unit: Hours per week (hr/week)
At baseline (first assessment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 10, 2025

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

November 22, 2025

First Submitted That Met QC Criteria

December 17, 2025

First Posted (Actual)

December 24, 2025

Study Record Updates

Last Update Posted (Actual)

December 24, 2025

Last Update Submitted That Met QC Criteria

December 17, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • KSVGH25-CT3-09

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No individual participant data (IPD) will be shared. The decision is based on institutional policy and the need to protect participant privacy and confidentiality. Only aggregated results will be reported in publications.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Older Adults, Balance

Clinical Trials on Static Balance Assessment Protocol

Subscribe